Nitric oxide and tissue destruction

Oral Diseases

Volumn 7, Issue 1, 2001, Pages 2-10

  Kendall, H K ^a   Marshall, R I ^a   Bartold, P M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Free radicals; Inflammation; Nitric oxide; Periodontal disease

Indexed keywords

FREE RADICAL; NITRIC OXIDE;

AUTOIMMUNE DISEASE; BIOSYNTHESIS; BONE METABOLISM; CELL PROTECTION; CYTOTOXICITY; EPITHELIUM; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; NONHUMAN; PATHOGENESIS; PERIODONTAL DISEASE; PRIORITY JOURNAL; REVIEW; TISSUE INJURY;

EID: 0035107862     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-0825.2001.70102.x     Document Type: Review

References (131)

1. A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases
2. Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines
3. Up-regulation of interleukin-1 beta stimulated interleukin-8 in human keratinocytes by nitric oxide
4. Regulation of inducible nitric oxide synthase mRNA levels by differentiation and cytokines in human keratinocytes
5. Feedback inhibition of nitric oxide synthase activity by nitric oxide
6. Nitric oxide and asthmatic inflammation
7. The effect of oxygen-derived free radicals on gingival proteoglycans and hyaluronic acid
8. Nitric oxide inhibits the secretion of T-helper 1 and T-helper 2 associated cytokines in activated human T cells
9. Biological and biochemical inhibitors of the NFκB/Rel proteins and cytokine synthesis
10. Matrix metalloproteinases. A review
11. Chondrocyte apoptosis induced by nitric oxide
12. LPS from Actinobacillus actinomycetemcomitans and production of nitric oxide in murine macrophages J774
13. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms
14. Nitric oxide in human skin: Current status and future prospects
15. Nitric oxide is a regulator of bone remodelling
16. Reactive oxygen species and antioxidants in inflammatory diseases
17. Calmodulin is a subunit of nitric oxide synthase from macrophages
18. Upregulation by recombinant human TGF-β of collagen production in cultured dermal fibroblasts mediated by the inhibition of nitric oxide signalin
19. Induction of nitric oxide synthase mRNA expression: Suppression by exogenous nitric oxide
20. Tyrosine kinase involvement in IL-1β induced expression of iNOS by beta-cells purified from islets of Langerhans
21. IL-1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: Activation of cyclooxygenase by nitric oxide
22. A one hour pulse with IL-1β induces formation of nitric oxide by rat islets of Langerhans: Evidence for tyrosine kinase signalling mechanism
23. Effects of nitric oxide on chemotaxis and endotoxin-induced interleukin-8 production in human neutrophils
24. Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kappaB activation in J774 macrophages
25. Nitric oxide acts in conjunction with proinflammatory cytokines to promote cell death in osteoblasts
26. Tumour necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict the growth of virulent Mycobacterium avium and to kill avirulent M. avium: Killing effector mechanism depends on the generation of reactive nitrogen intermediates
27. Human monocytes/macrophages: NO or no NO?
28. Biologic basis of interleukin-1 in disease
29. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate
30. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury
31. Update on the mechanisms of immune suppression of injury and immune modulation
32. Nitric oxide synthase isozymes- characterization, purification, molecular cloning, and functions
33. Nitric oxide synthase expression in bone cells
34. Free radical chemistry of nitric oxide: Looking at the dark side
35. In vivo exposure to Porphyromonas gingivalis up-regulates nitric oxide but suppresses tumour necrosis factor-α production by cultured macrophages
36. Studies on relaxation of rabbit aorta by sodium nitrite: The basis for the proposal that the acid-activable inhibitory factors from retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide
37. Exogenous, but not endogenous nitric oxide increases proliferation rates in senescent human fibroblasts
38. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo
39. Molecular biology of nitric oxide synthases
40. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis
41. Minocycline reduces gingival collagenolytic activity during diabetes: Preliminary observations and proposed new mechanism of action
42. Tetracyclines inhibit collagenase activity: A new mechanism for treatment of periodontal disease
43. Tetracyclines inhibit connective tissue breakdown: New therapeutic implications for an old family of drugs
44. Nitric oxide I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation
45. Inhibition of nitric oxide synthase as a potential therapeutic target
46. The role of glutathione in the transport and catabolism of nitric oxide
47. 2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and independent mechanism in rat osteoblasts in vitro
48. NADPH-diaphorase activity in nerves and Schwann cells in the periodontal ligament of rat incisor teeth
49. Signal transduction mechanisms involving nitric oxide
50. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
51. Apoptotic cell death triggered by nitric oxide in pancreatic-β cells
52. Nitric oxide synthases in mammals
53. The host response to the microbial challenge in periodontitis: Assembling the players
54. Nitric oxide: Cytotoxicity versus cytoprotection - How, why, when and where?
55. Central regulation of autonomic function: No brakes?
56. Inhibition of tumour cell ribonucleotide reductase by macrophage-derived nitric oxide
57. A tutorial on the diffusibility and reactivity of free nitric oxide
58. Nitric oxide: A new endogenous immunomodulator
59. Kinetic modelling of the nitric oxide gradient generated in vitro by adherent cells expressing inducible nitric oxide synthase
60. Nitric oxide in infectious and autoimmune diseases
61. Nonspecific defense mechanism: The role of nitric oxide
62. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th 1 activity via the modulation of the induction of nitric oxide synthase on macrophages
63. Synthesis and properties of nitric oxide
64. Nitric oxide in the immune system
65. Nitric oxide in the peripheral nervous system
66. Natural history of periodontal disease in man: Rapid, moderate and no loss of attachment in Sri Lankan labourers 14-46 years of age
67. Protective effects of mercaptoethylguanidine, a selective inhibitor of nitric oxide synthase, in ligature-induced periodontitis in the rat
68. Nitric oxide synthase containing nerves in the cat and dog dental pulp and gingiva
69. A specific sequence of stimulation is required to induce synthesis of the anti-microbial molecule nitric oxide by mouse macrophages
70. Nitric oxide, a novel biologic messenger
71. Osteoclastic inhibition: An action of nitric oxide not mediated by cyclic GMP
72. Induction of nitric oxide production by polysides from the cell walls of Streptococcus mutans OMZ 175, a gram-positive bacterium, in the rat aorta
73. Nitric oxide synthesis is increased in periodontal disease
74. New ways to ventilate newborns in acute respiratory failure
75. Suppression of inflammatory arthritis by simultaneous inhibition of nitric oxide synthase and NADPH oxidase
76. Modulation of superoxide dependent oxidation and hydroxylation reactions by nitric oxide
77. Role of oxidants in microbial pathophysiology
78. Nitric oxide in inflammation and immune response
79. The L-arginine-nitric oxide pathway
80. Nitric oxide: Physiology, pathophysiology and pharmacology
81. Degradation of glycosaminoglycans by reactive oxygen species, derived from stimulated polymorphonuclear leukocytes
82. The modification of alveolar bone proteoglycans by reactive oxygen species in vitro
83. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-α and IFN-γ through a nitric oxide-dependent mechanism
84. Nitric oxide activates metalloprotease enzymes in articular cartilage
85. Regulation of biosynthesis of nitric oxide
86. Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo
87. Sildenafil: A new therapy for erectile dysfunction
88. Inflammation, immunoregulation and inducible nitric oxide synthase
89. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: A novel mechanism for procollagenase activation involving nitric oxide
90. The role of inflammatory mediators in the pathogenesis of periodontal disease
91. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
92. Periodontal diseases: Epidemiology
93. Biological aspects of reactive nitrogen species
94. Langerhans cells express inducible nitric oxide synthase and produce nitric oxide
95. Endothelial function in health and disease: New insights into the genesis of cardiovascular disease
96. Nitric oxide and bone
97. Nitric oxide: Acytokine induced regulator of bone resorption
98. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase
99. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages
100. Activation of murine macrophages by lipoprotein and lipooligosaccharide of Treponema denticola
101. Nitric oxide activates cyclooxygenase enzymes
102. The nitric oxide synthase family of proteins
103. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes
104. Intercellular action of nitric oxide in the adult rat cerebellar slices
105. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the reducible isoforms
106. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes
107. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells
108. Cytokine production by epithelial cells
109. Redox signaling: Nitrosylation and related target interactions of nitric oxide
110. N-Monomethyl arginine an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats
111. Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumour target cells
112. Interactions between non-immune host cells and the immune system during periodontal disease: Role of the gingival keratinocyte
113. DNA damage induced by peroxynitrite: Subsequent biological effects
114. Mercaptoethylguanidine and related guanidine nitric oxide inhibitors react with peroxynitrite and protect against peroxynitrite-induced oxidative damage
115. Beneficial effects and improved survival in rodent models of septic shock and S-methyl-isothiourea sulphate, a novel, potent and selective inhibitor of inducible nitric oxide synthase
116. Cytokine regulation in the synthesis of nitric oxide in vivo by chronically infected human polymorphonuclear leucocytes
117. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1
118. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells
119. Neutrophil migration into the gingival sulcus is associated with transepithelial gradients of interleukin-8 and ICAM-1
120. Chemically modified tetracyclines inhibit inducible nitric oxide synthase expression and nitric oxide production in cultured rat mesangial cells
121. Nitric oxide regulates endotoxin-derived TNF-α production by human neutrophils
122. Role of nitric oxide in autoimmunity: Short analytical review
123. Review article: New insights into prostaglandins and mucosal defense
124. Human dermal fibroblasts produce nitric oxide and express both consitutive and inducible nitric oxide synthase isoforms
125. Nitric oxide synthase expression and nitric oxide production are reduced in hypertrophic scar tissue and fibroblasts
126. Altered immune responses in mice lacking inducible nitric oxide synthase
127. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): Analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages
128. Nonenzymatic nitric oxide production in humans
129. Interleukin-1β induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic islets
130. Mercaptoalkylguanidines are direct inhibitors of cyclo-oxygenase activity
131. MDP (Lysyl) GDP, a nontoxic muramyl dipeptide derivative, inhibits cytokine production by activated macrophages and protects mice from phorbol ester- and oxazolone-induced inflammation